Skip to main content
SpringerLink
Log in

Immunology: Serological Tests That Help Diagnose Kidney Diseases

  • Chapter
  • First Online:
Understanding Kidney Diseases

  • 912 Accesses

Abstract

In this chapter we explain:

  • When immunology tests are most helpful

  • How diagnostic information is gained from measuring:

    • Immunoglobulins and free light chains

    • Anti-nuclear antibody

    • Complement components C3 and C4

    • Anti-neutrophil cytoplasmic antibody (ANCA)

    • Anti-glomerular basement membrane antibody

    • Anti-phospholipase A2 receptor antibody

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yatim KM, Lakkis FG. A Brief Journey through the immune system. CJASN CJN.10031014. https://doi.org/10.2215/CJN.10031014. http://cjasn.asnjournals.org/content/early/2015/04/06/CJN.10031014.full.

  2. Kitching AR, Hutton HL. The players: cells involved in glomerular disease. Clin J Am Soc Nephrol. 2016;11(9):1664–74. https://doi.org/10.2215/CJN.13791215. Epub 2016 Apr 12. http://cjasn.asnjournals.org/cgi/pmidlookup?view=long&pmid=27073196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Jefferson JA. Complications of immunosuppression in glomerular disease. Clin J Am Soc Nephrol. 2018;13(8):1264–75. https://doi.org/10.2215/CJN.01920218. Epub 2018 Jul 24. https://cjasn.asnjournals.org/content/13/8/1264.long.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Maeda A, Gohda T, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy. Clin Lab Anal. 2003;17(3):73–6. http://onlinelibrary.wiley.com/doi/10.1002/jcla.10071/abstract;jsessionid=A271E49EC0DF8F1FF6196265F755FA83.f02t02.

    Article  CAS  Google Scholar 

  5. Rosner MH, Edeani A, Yanagita M, Glezerman IG, Leung N, American Society of Nephrology Onco-Nephrology Forum. Paraprotein-related kidney disease: diagnosing and treating monoclonal gammopathy of renal significance. Clin J Am Soc Nephrol. 2016;11(12):2280–7. Epub 2016 Aug 15. https://cjasn.asnjournals.org/content/11/12/2280.long.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Motwani SS, Herlitz L, Monga D, Jhaveri KD, Lam AQ, American Society of Nephrology Onco-Nephrology Forum. Paraprotein-related kidney disease: glomerular diseases associated with paraproteinemias. Clin J Am Soc Nephrol. 2016;11(12):2260–72. Epub 2016 Aug 15. https://cjasn.asnjournals.org/content/11/12/2260.long.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Leung N, Drosou ME, Nasr SH. Dysproteinemias and Glomerular Disease. Clin J Am Soc Nephrol. 2018;13(1):128–39. https://doi.org/10.2215/CJN.00560117. Epub 2017 Nov 7. https://cjasn.asnjournals.org/content/13/1/128.long.

    Article  PubMed  Google Scholar 

  8. Ritchie J, Assi LK, Burmeister A, Hoefield R, Cockwell P, Kalra PA. Association of serum Ig free light chains with mortality and ESRD among patients with nondialysis-dependent CKD. CJASN CJN.09660914; published ahead of print March 30, 2015. https://doi.org/10.2215/CJN.09660914. http://cjasn.asnjournals.org/content/early/2015/03/30/CJN.09660914.

  9. McTaggart MP, Lindsay J, Kearney EM. Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients. Am J Clin Pathol. 2013;140(6):890–7. https://doi.org/10.1309/AJCP25IHYLEWCAHJ. https://academic.oup.com/ajcp/article/140/6/890/1761562.

    Article  PubMed  Google Scholar 

  10. Rezk T, Lachmann HJ, Fontana M, Sachchithanantham S, Mahmood S, Petrie A, Whelan CJ, Pinney JH, Foard D, Lane T, Youngstein T, Wechalekar AD, Bass P, Hawkins PN, Gillmore JD. Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor. Kidney Int. 2017;92(6):1476–83. https://doi.org/10.1016/j.kint.2017.05.004. Epub 2017 Jul 18. https://www.kidney-international.org/article/S0085-2538(17)30328-9/fulltext.

    Article  CAS  PubMed  Google Scholar 

  11. Howie AJ, Brewer DB, Howell D, Jones AP. Physical basis of colors seen in Congo red-stained amyloid in polarized light. Lab Invest. 2008;88(3):232–42. https://doi.org/10.1038/labinvest.3700714. Epub 2007 Dec 31. http://www.nature.com/labinvest/journal/v88/n3/full/3700714a.html.

    Article  CAS  PubMed  Google Scholar 

  12. Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–35. https://doi.org/10.2215/CJN.05780616. Epub 2016 Nov 7. https://cjasn.asnjournals.org/content/12/5/825.long.

    Article  PubMed  Google Scholar 

  13. Thurman JM, Nester CM. All things complement. Clin J Am Soc Nephrol. 2016;11(10):1856–66. https://doi.org/10.2215/CJN.01710216. Epub 2016 Jun 23. https://cjasn.asnjournals.org/content/11/10/1856.long.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fakhouri F, Frémeaux-Bacchi V, Noël LH, Cook HT, Pickering MC. C3 glomerulopathy: a new classification. Nat Rev Nephrol. 2010;6(8):494–9. https://doi.org/10.1038/nrneph.2010.85. Epub 2010 Jul 6. http://www.nature.com/nrneph/journal/v6/n8/full/nrneph.2010.85.html.

    Article  CAS  PubMed  Google Scholar 

  15. Paixão-Cavalcante D, López-Trascasa M, Skattum L, Giclas PC, Goodship TH, Rodríguez de Córdoba S, Truedsson L, Morgan BP, Harris CL. Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int. 2012;82:1084–92. https://doi.org/10.1038/ki.2012.250. http://www.nature.com/ki/journal/v82/n10/full/ki2012250a.html.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. JASN. 2008;19:1855–64. https://doi.org/10.1681/ASN.2008010092. http://jasn.asnjournals.org/content/19/10/1855.full

    Article  PubMed  Google Scholar 

  17. Jennette JC, Nachman PH. ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol. 2017;12(10):1680–91. https://doi.org/10.2215/CJN.02500317. https://cjasn.asnjournals.org/content/12/10/1680.long.

    Article  PubMed  PubMed Central  Google Scholar 

  18. McAdoo SP, Tanna A, Hrušková Z, Holm L, Weiner M, Arulkumaran N, Kang A, Satrapová V, Levy J, Ohlsson S, Tesar V, Segelmark M, Pusey CD. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int. 2017;92(3):693–702. https://doi.org/10.1016/j.kint.2017.03.014. PubMed PMID: 28506760; PubMed Central PMCID: PMC5567410. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567410/#__ffn_sectitle.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Jennette JC, Falk RJ. ANCAs are also antimonocyte cytoplasmic autoantibodies. Clin J Am Soc Nephrol. 2014;10:4–6. https://doi.org/10.2215/CJN.11501114. http://cjasn.asnjournals.org/content/10/1/4.short.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Schoenermarck U, Csernok E, Gross WL. Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions. Nephrol Dial Transplant. 2014;30:i46–52. https://doi.org/10.1093/ndt/gfu398. http://ndt.oxfordjournals.org/content/30/suppl_1/i46.abstract.

    Article  CAS  Google Scholar 

  21. Knight A, Ekbom A, Brandt L, Askling J. What is the significance in routine care of c-ANCA/PR3-ANCA in the absence of systemic vasculitis? A case series. Clin Exp Rheumatol. 2008;26(3 Suppl 49):S53–6. https://www.clinexprheumatol.org/article.asp?a=3375.

    CAS  PubMed  Google Scholar 

  22. Antonelou M, Perea Ortega L, Harvey J, Salama A. Anti-myeloperoxidase antibody positivity in patients without primary systemic vasculitis. Clin Exp Rheumatol. 2019;37 Suppl 117(2):86–9. https://www.clinexprheumatol.org/abstract.asp?a=12869.

    PubMed  Google Scholar 

  23. Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P, Tervaert JWC. ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. JASN. 2015;26:537–42. https://doi.org/10.1681/ASN.2013111233. http://jasn.asnjournals.org/content/26/3/537.abstract.

    Article  CAS  PubMed  Google Scholar 

  24. McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12(7):1162–72. https://doi.org/10.2215/CJN.01380217. https://cjasn.asnjournals.org/content/12/7/1162.long.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. McQuarrie EP. Anti-phospholipase A2 receptor antibodies in primary membranous nephropathy-10 key points. Nephrol Dial Transplant. 2018;33(2):212–3. https://doi.org/10.1093/ndt/gfx366. https://academic.oup.com/ndt/article/33/2/212/4834145.

    Article  CAS  PubMed  Google Scholar 

  26. Tomas NM, Beck LH, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay A-S, Debayle D, Merchant M, Klein J, Salant DJ, Stahl RAK, Lambeau G. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014;371:2277–87. https://doi.org/10.1056/NEJMoa1409354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int. 2019;95(2):429–38. https://doi.org/10.1016/j.kint.2018.10.021. https://www.kidney-international.org/article/S0085-2538(18)30822-6/fulltext.

    Article  CAS  PubMed  Google Scholar 

  28. Hoxha E, Harendza S, Pinnschmidt HO, Tomas NM, Helmchen U, Panzer U, Stahl RA. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy. Nephrol Dial Transplant. 2015;30(11):1862–9. https://doi.org/10.1093/ndt/gfv228. https://academic.oup.com/ndt/article/30/11/1862/2459994.

    Article  CAS  PubMed  Google Scholar 

  29. De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FCA. Proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol. 2017;28(2):421–30. https://doi.org/10.1681/ASN.2016070776. Epub 2016 Oct 24. https://jasn.asnjournals.org/content/28/2/421.long.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Birmingham Heartlands Hospital, Birmingham, UK

    Hugh C. Rayner & Mark E. Thomas

  2. Birmingham Children’s Hospital, Birmingham, UK

    David V. Milford

Authors
  1. Hugh C. Rayner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark E. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David V. Milford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rayner, H.C., Thomas, M.E., Milford, D.V. (2020). Immunology: Serological Tests That Help Diagnose Kidney Diseases. In: Understanding Kidney Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-43027-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-43027-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-43026-9

  • Online ISBN: 978-3-030-43027-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation